TECHNOLOGY COMMERCIALIZATION
SEARCH
Available Technologies:
Life Science
|
Physical Science
|
Research Tools
|
Software
Search Results - cancer+risk
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Translation Regulated (TR)-Mediated Gene Expression: Novel Expression and Reporter Vectors
This is a cell based vector system that is able to monitor the transition, in cell lines, from Cap dependent to Cap independent translation. This shift is critical in determining if a cell, that is placed under significant stress (such as treatment with a chemotherapeutic agent), recovers or undergoes programmed cell death (apoptosis). This information...
Published: 2/6/2014
|
Inventor(s):
Leon Carlock
,
Maria Cypher
Keywords(s):
Animal Model
,
Anti-cancer
,
Cancer
,
Cancer risk
,
Cancer Therapies
,
Diagnostics
,
Imaging
,
Therapeutics
Category(s):
Life Science
,
Diagnostics
,
Research tools
,
Assays
,
Cell lines
Galectin-3 Single Nucleotide Polymorphism rs4644 Predicts Human
Cancer Risk
Associated with Racial Disparity
This invention is a new diagnostic tool which allows prediction of
cancer risk
based on a single nucleotide polymorphism of a gene whose protein is over-expressed in various cancers. The polymorphism results in a single amino acid change. DNA analysis demonstrated that 98% of cancer patients tested had the mutation while normal donors did not....
Published: 3/31/2014
|
Inventor(s):
Avraham Raz
,
Pratima NangiA-Maker
,
Vitaly Balan
Keywords(s):
Biotechnology
,
Cancer
,
Cancer risk
,
Diagnostics
Category(s):
Diagnostic
,
Life Science
,
Oncology
GlyB4 Fusion with Neuregulin Heparin-Targeting Domain to Block Neuregulin Signaling
We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Schwann...
Published: 2/6/2014
|
Inventor(s):
Jeffrey Loeb
,
Qunfang Lee
Keywords(s):
Anti-cancer
,
Biotechnology
,
Cancer risk
,
Cancer Therapies
,
Drug Delivery
,
Drug Target
,
Epilepsy
Category(s):
Life Science
,
Drug Delivery
,
Other